These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21167645)

  • 1. Reproductive disruption in Fasciola hepatica associated with incomplete efficacy of a new experimental formulation of triclabendazole.
    Scarcella S; Fiel C; Guzman M; Alzola R; Felipe A; Hanna RE; Fairweather I; McConnell S; Solana H
    Vet Parasitol; 2011 Mar; 176(2-3):157-64. PubMed ID: 21167645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a parenteral ivermectin/closantel injection on the growth and reproductive development of early immature Fasciola hepatica in cattle.
    Hanna RE; Cromie L; Taylor SM; Couper A
    Vet Parasitol; 2006 Nov; 142(1-2):78-90. PubMed ID: 16901648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the comparative efficacy of a moxidectin plus triclabendazole pour-on solution against adult and immature liver fluke, Fasciola hepatica, in cattle.
    Geurden T; Bartram D; Van Brussel L; Bo L; Scott-Baird E; Rugg D
    Vet Parasitol; 2012 Oct; 189(2-4):227-32. PubMed ID: 22579500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
    Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of triclabendazole against Fasciola hepatica and Fascioloides magna in naturally infected calves.
    Craig TM; Huey RL
    Am J Vet Res; 1984 Aug; 45(8):1644-5. PubMed ID: 6476577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks.
    Hanna RE; Forster FI; Brennan GP; Fairweather I
    Vet Parasitol; 2013 Jan; 191(3-4):240-51. PubMed ID: 23062689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts.
    Hanna RE; Edgar H; Moffett D; McConnell S; Fairweather I; Brennan GP; Trudgett A; Hoey EM; Cromie L; Taylor SM; Daniel R
    Vet Parasitol; 2008 Nov; 157(3-4):222-34. PubMed ID: 18774647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced reproductive potential of Fasciola hepatica surviving in cattle treated with albendazole.
    Lang BZ; Hall RF; Kirstein KW; Wescott RB
    Vet Med Small Anim Clin; 1980 Dec; 75(12):1853-7. PubMed ID: 6906899
    [No Abstract]   [Full Text] [Related]  

  • 12. Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2014 Jul; 141(8):1064-79. PubMed ID: 24889697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of clorsulon and albendazole against Fasciola hepatica in cattle.
    Kilgore RL; Williams ML; Benz GW; Gross SJ
    Am J Vet Res; 1985 Jul; 46(7):1553-5. PubMed ID: 4026039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasciola hepatica: comparative effects of host resistance and parasite intra-specific interactions on size and reproductive histology in flukes from rats infected with isolates differing in triclabendazole sensitivity.
    Hanna RE; Gordon AW; Moffett D; Edgar HW; Oliver LF; McConnell S; Shaw L; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Jun; 178(3-4):251-63. PubMed ID: 21333449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFficacy of albendazole for treatment of naturally acquired fasciola hepatica in calves.
    Malone JB; Smith PH; Loyacano AF; Hembry FG; Brock LT
    Am J Vet Res; 1982 May; 43(5):879-81. PubMed ID: 7091853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2011 Apr; 177(1-2):79-89. PubMed ID: 21163580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the flukicide treatment policy for dairy cattle in Galicia (NW Spain).
    Mezo M; González-Warleta M; Castro-Hermida JA; Ubeira FM
    Vet Parasitol; 2008 Nov; 157(3-4):235-43. PubMed ID: 18774648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2011 May; 177(3-4):305-15. PubMed ID: 21208747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2012 Feb; 184(1):37-47. PubMed ID: 21872399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.